MEDBOT-B: CONTINUING CONNECTED TRANSACTIONS AND CLOSURE OF REGISTER OF MEMBERS FOR THE EGM
MEDBOT-B: CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2022, 2022 WORK REPORT OF THE SUPERVISORY COMMITTEE, PROPOSED 2022 ANNUAL PROFIT DISTRIBUTION PLAN, 2023 ANNUAL FINANCIAL BUDGET PLAN, GENERAL MANDATE TO BUY BACK SHARES AND ISSUE N
MEDBOT-B: CONTINUING CONNECTED TRANSACTION
MEDBOT-B: (1) PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD; (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) RESIGNATION AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (4) UNCOVERED DEFICIT OF THE COMPANY AMOUNTI
MEDBOT-B: 2021 ANNUAL GENERAL MEETING CIRCULAR
MEDBOT-B: PROPOSED ADOPTION OF THE SHARE OPTION SCHEME; PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION;NOTICE OF 2022 SECOND EXTRAORDINARY GENERAL MEETIN;NOTICE OF 2022 FIRST DOMESTIC SHAREHOLDERS'' CLASS MEETING; AND NOTICE OF 2022 FIRST H SHAREHOLDERS
MEDBOT-B: (I) PROPOSED ADOPTION OF SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION
MEDBOT-B: (I) PROPOSED ADOPTION OF H SHARE AWARD SCHEME; (II) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (III) GENERAL MANDATE TO ISSUE ADDITIONAL SHARES; AND (IV) NOTICE OF 2022 FIRST EXTRAORDINARY GENERAL MEETING
MEDBOT-B: (I) PROPOSED ADOPTION OF H SHARE AWARD SCHEME; (II) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (III) CLOSURE OF REGISTER OF MEMBERS FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON 10 FEBRUARY 2022
MEDBOT-B: BLUE APPLICATION FORM
MEDBOT-B: GREEN APPLICATION FORM
MEDBOT-B: GLOBAL OFFERING
No Data